• Regulatory NewsRegulatory News

    EU Regulatory Roundup: MHRA Offers Advice on use of Brand Names to Prescribe Drugs

    Welcome to our European Regulatory Roundup, our weekly overview of the top EU   regulatory news.   MHRA Offers Advice on use of Brand Names to Prescribe Drugs   The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has updated its guideline on the naming of medicinal products. MHRA’s most substantive change is the addition of a new section that provides general recommendations for brand naming and prescribing.   In some cases, products are appro...
  • Regulatory NewsRegulatory News

    Asia Regulatory Roundup: China Tightens Genetic Material Rules, Places Extra Restrictions on Foreigners

    Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.   China Tightens Genetic Material Rules, Places Extra Restrictions on Foreigners   China is set to tighten restrictions on the use of human materials including DNA, organs, blood and tissues. The rules require foreign organizations to team up with local partners to use human genetic materials and otherwise place extra limits on their access to samples taken in China. ...
  • Regulatory NewsRegulatory News

    EU Regulatory Roundup: MHRA Advises Against Use of Paclitaxel Devices Amid Mortality Fears

    Welcome to our European Regulatory Roundup, our weekly overview of the top EU   regulatory news. MHRA Advises Against Use of Paclitaxel Devices Amid Mortality Fears   The United Kingdom’s (UK) Medicines and Healthcare products Regulatory Agency (MHRA) has said not to use devices featuring paclitaxel in the routine treatment of patients with intermittent claudication. MHRA took the action after finding the potential mortality risk outweighs the benefits in this pat...
  • Regulatory NewsRegulatory News

    Asia Regulatory Roundup: China Reports 25% Fall in Initial Medical Device Registrations

    Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.   China Reports 25% Fall in Initial Medical Device Registrations   China’s National Medicinal Products Administration (NMPA) has reported a 25% year-on-year drop in initial registrations of medical devices. The fall dragged the overall level of registration activity down to its lowest level since China began publishing data on the topic in 2013.   Last year, NMPA a...
  • Regulatory NewsRegulatory News

    EU Regulatory Roundup: Swissmedic Sees Surge in Inquiries as Safety Scares, Brexit Fuel Questions

    Welcome to our European Regulatory Roundup, our weekly overview of the top EU   regulatory news.   Swissmedic Sees Surge in Inquiries as Safety Scares, Brexit Fuel Questions   The Swiss Agency for Therapeutic Products (Swissmedic) has seen a surge in the number of inquiries from the public and specialists. Swissmedic attributed the trend to concerns about quality problems such as the valsartan scandal and uncertainty about the consequences of Brexit.   In 201...
  • Regulatory NewsRegulatory News

    Asia Regulatory Roundup: China Approves Amgen and GSK Products Under Overseas Fast-Track Scheme

    Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.   Philippine FDA Shares Draft Rules on Clinical Trial Conduct for Comment   The Philippine Food and Drug Administration (FDA) has issued draft regulations on the conduct of clinical trials. The document sets out general principles covering clinical trials run in the Philippines, as well as more specific points addressing each step from application to termination.   ...
  • Regulatory NewsRegulatory News

    EU Regulatory Roundup: EMA’s PRAC Calls for Withdrawal of Fenspiride Cough Medicines, Temporary Restrictions on Xeljanz

    Welcome to our European Regulatory Roundup, our weekly overview of the top EU   regulatory news.   PRAC Calls for Withdrawal of Fenspiride Cough Medicines, Temporary Restrictions on Xeljanz   The Pharmacovigilance Risk Assessment Committee (PRAC) has recommended the withdrawal of cough medicines containing fenspiride from the European market. PRAC made the recommendation at a meeting at which it also placed temporary restrictions on the use of Pfizer’s Xeljanz. ...
  • Regulatory NewsRegulatory News

    Asia Regulatory Roundup: TGA Releases Advertising Breach ‘Stop Clock’ Policies as Legal Case Advances

    Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.   TGA Releases Advertising Breach ‘Stop Clock’ Policies as Legal Case Advances   Australia’s Therapeutic Goods Administration (TGA) has discussed when it will stop the clock in its handling of complaints about advertising. TGA updated its policy on the same day as it shared new details of its legal case against Peptide Clinics Australia.   The original TGA guide to...
  • Regulatory NewsRegulatory News

    Asia Regulatory Roundup: Indian High Court Stays Profiteering Proceedings Against Abbott

    Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.   Indian High Court Stays Profiteering Proceedings Against Abbott   The Delhi High Court has hit pause on anti-profiteering proceedings against Abbott. The ruling frees Abbott from the need to pay a fine imposed by the National Anti-Profiteering Authority (NAPA) while the constitutional validity of the punishment is considered.   NAPA fined Abbott Rs 96.59 lakh ($1...
  • Regulatory NewsRegulatory News

    EU Regulatory Roundup: Ireland Hires IVD, Medical Device Staff Ahead of EU Legislative Changes

    Welcome to our European Regulatory Roundup, our weekly overview of the top EU   regulatory news.   Ireland Hires IVD, Medical Device Staff Ahead of EU Legislative Changes   Ireland’s Health Products Regulatory Agency (HPRA) has begun recruiting for medical device and in vitro diagnostic (IVD) positions ahead of the implementation of Europe-wide legislative changes.   HPRA released advertisements for two positions this week, both of which refer to the incomi...
  • Regulatory NewsRegulatory News

    Asia Regulatory Roundup: China Reviews Supervision of Cell and Gene Therapies Through Regulatory Action Plan

    Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.   TGA Proposes Fining Individuals $15,000 for Drug Shortage Reporting Failings   Australia’s Therapeutic Goods Administration (TGA) will hit individuals who fail to comply with its new drug shortage reporting rules with fines of up to AU$21,000 ($15,000). TGA may fine companies that breach the rules 10 times as much in a bid to ensure compliance with the requirements. ...
  • Regulatory NewsRegulatory News

    EU Regulatory Roundup: MHRA Accused of Appalling Treatment of Families in Pregnancy Test Review

    Welcome to our European Regulatory Roundup, our weekly overview of the top EU   regulatory news.   MHRA Accused of Appalling Treatment of Families in Pregnancy Test Review   A politician has accused the United Kingdom drug regulator of behaving “appallingly” to families who gave evidence to a panel that assessed the link between hormone pregnancy tests and birth defects or miscarriage.   The accusation against the Medicines and Healthcare product Regulatory A...